OpenLB
Open Library of Bioscience
Advanced Search
Blood advances
Apr 08, 2025;9 (7): 1492-1496.

Desensitization to calaspargase pegol appears to be less successful than pegaspargase.

Milre Matherne, John C Panetta, Jaclyn Hopp, Hiroto Inaba, Ching-Hon Pui, Seth E Karol, Hope D Swanson
Author Information
  1. Milre Matherne: Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. ORCID
  2. John C Panetta: Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. ORCID
  3. Jaclyn Hopp: Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN.
  4. Hiroto Inaba: Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN. ORCID
  5. Ching-Hon Pui: Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN. ORCID
  6. Seth E Karol: Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN. ORCID
  7. Hope D Swanson: Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. ORCID
PMID: 39903102 DOI: 10.1182/bloodadvances.2024015455

Abstract

No abstract text available.

Journal Article

Word Cloud

Created with Highcharts 10.0.0Desensitizationcalaspargasepegolappearslesssuccessfulpegaspargase

Similar Articles

Cited By

No available data.